BSN Medical's Sales and EBITDA for 2016

STOCKHOLM, March 9, 2017 /PRNewswire/ -- As SCA communicated in December 2016, the Group has entered into an agreement to acquire BSN medical, a leading medical solutions company. Closing is expected to take place during the second quarter 2017. BSN medical's sales for 2016 amounted to EUR 850m (SEK 8,038m) and adjusted EBITDA1) for 2016 amounted to EUR 210m (SEK 1,986m).

1)Excluding items affecting comparability

NB: This information is information that SCA is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 20:00 CET on March 9, 2017. 

Karl Stoltz, Media Relations Manager, +46-8-788-51-55  

CONTACT:

For additional information please contact:

Johan Karlsson, Vice President Investor Relations, 46 (0)8 788 51 30

Karl Stoltz, Media Relations Manager, 46 (0)8 788 51 55

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/sca/r/bsn-medical-s-sales-and-ebitda-for-2016,c2209205

The following files are available for download:

http://mb.cision.com/Main/600/2209205/640475.pdf     BSN medical’s sales and EBITDA for 2016

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bsn-medicals-sales-and-ebitda-for-2016-300421406.html

SOURCE SCA